Tag: Cancer: Prostate
Single PSA Screening Doesn’t Cut Prostate Cancer Mortality
But screening is associated with increased detection of low-risk prostate cancer
MRI Risk Model May Cut Biopsy Use in Suspected Prostate Cancer
Inclusion of MRI-derived parameters can maintain high rate of diagnosis of clinically significant cancer
FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer
First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer
Criteria for Prostate Cancer Trials Disproportionately Exclude Blacks
Trials sponsored by academic investigators, cooperative groups more likely to use these criteria
Apalutamide Active in Castration-Resistant Prostate Cancer
Apalutamide prolongs metastasis-free survival in non-metastatic castration-resistant prostate cancer
Obesity, Metabolic Syndrome Ups Risk of Recurrent Prostate Cancer
Following radical prostatectomy, higher BMI increases risk of recurrence for prostate cancer
Mediterranean Diet May Lower Risk of Aggressive Prostate CA
Prudent or Western pattern diets had no association with prostate cancer risk
Mortality Up for Some Cancers in Urban-Dwelling Native Americans
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
Less Frequent Biopsy May Be Option in Prostate Cancer Care
Consequences of biennial versus annual biopsies similar during active surveillance
Heterogeneity of PET/CT Imaging Phenotype Prognostic in mCRPC
Assessments of androgen receptor, glycolysis prognostic in castration-resistant prostate Cancer
